Weibo Xia

7.4k citations
290 papers · 4.2k indexed · 2 hit papers · h-index 30

Weibo Xia

270 papers receiving 4.2k citations

Hit Papers

Goal-directed osteop...33201820262020202350100150200

Peers

Weibo Xia
Comparison fields: 5 of 134
  • Orthopedics and Sports Medicine 1.2k
  • Nephrology 941
  • Rheumatology 619
  • Oncology 1.1k
  • Genetics 1.0k
Replace Karine Briot with:
Karine Briot France
Barbara C. Silva United States
Lars Melholt Rasmussen Denmark
Justine Bacchetta France
Neal X. Chen United States
Pablo Ureña France
Carol C. Pilbeam United States
D. Sudhaker Rao United States
Munro Peacock United Kingdom
Ombretta Viapiana Italy
Weibo Xia relative to Karine Briot France Karine Briot's profile →
Citations per field
00.5×1.5×2.3×
Karine Briot · 1×
Citations per year

Countries citing papers authored by Weibo Xia

Since Specialization
Citations

This map shows the geographic impact of Weibo Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Xia more than expected).

Fields of papers citing papers by Weibo Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibo Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Xia. The network helps show where Weibo Xia may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Weibo Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weibo Xia Line = papers co-authored together Weibo Xia links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20245
3 20242
4 20231
5 20232
6 20236
7 20232
8 20232
9 20231
10 20230
11 20220
12 20220
13 20212
14 20212
15 201929
16 201713
17 201528
18 201411
19 201242
20 20073

About Weibo Xia

Weibo Xia is a scholar working on Nephrology, Orthopedics and Sports Medicine, Oncology, Genetics and Rheumatology, having authored 290 papers that have together received 4.2k indexed citations. Recurring topics across this work include Bone health and treatments (83 papers), Bone health and osteoporosis research (81 papers), Parathyroid Disorders and Treatments (76 papers), Connective tissue disorders research (50 papers), Bone Metabolism and Diseases (34 papers), Vitamin D Research Studies (29 papers), Genetic Syndromes and Imprinting (24 papers) and Bone and Joint Diseases (22 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.2k citations), Nephrology (941 citations), Rheumatology (619 citations), Oncology (1.1k citations) and Genetics (1.0k citations). Weibo Xia has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yan Jiang, Xiaoping Xing, Ou Wang, Mei Li, Yu Fan, Min Nie, Fang Lv, Xunwu Meng, Wei Yu and Ning Jiang. Their work appears in journals such as Osteoporosis International, Calcified Tissue International, Frontiers in Endocrinology, The Journal of Clinical Endocrinology & Metabolism and Bone.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026